Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The American clinical-stage GLP-1 specialist is the maker of pemvidutide, which is being evaluated in phase 2 trials for obesity and nonalcoholic steatohepatitis (NASH)
It mimics the action of the natural hormone but has improved stability and a longer half-life, allowing for less frequent dosing (12)
Patients with a personal or family history of thyroid cancer or multiple endocrine neoplasia syndrome type 2 (MEN 2) should not use Rybelsus
This helps identify whether specific side effects are medication-specific or transition-specific
US$ 28.40
US$ 25.81
US$ 28.81
US$ 21.61
